Amarin Corporation Investor Relations Material
Latest events
Q4 2023
Amarin Corporation
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Amarin Corporation plc
Access all reports
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's lead drug is Vascepa (icosapent ethyl) capsules, which are used in the treatment of dyslipidemia; additionally, its product portfolio includes Vascepa combination studies with ezetimibe and with other lipid-modifying agents. The company also develops PEGylated lipase inhibitors for patients suffering from hypertriglyceridemia in worldwide markets.
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States